Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › AAV vectors for gene therapy

AAV vectors for gene therapy

US Patent 6632670 · Granted Oct 14, 2003

Estimated economic value: $106,543,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Gene therapy for treating propionic acidemia2025
Compositions and methods for treating and preventing macular degeneration2025
Gene therapy constructs for treating Wilson disease2025
Use of iNOS inhibitors to increase viral yield in culture2022
Method of treating transplant rejection with silent Fc variants of anti-CD40 ant2021
Fusion proteins comprising PDGF and VEGF binding portions and methods of using t2021
Gene therapy for amyotrophic lateral sclerosis and other spinal cord disorders2021
Production of oversized adeno-associated vectors2020
Compositions and methods for treating and preventing macular degeneration2020
Nucleic acids encoding silent Fc variants of anti-CD40 antibodies2019
Nucleic acids encoding fusion proteins comprising PDGF and VEGF binding portions2019
Gene therapy for amyotrophic lateral sclerosis and other spinal cord disorders2018